CAJ | 학술논문

目的观察复方甘草酸苷片联合咪唑斯汀治疗慢性荨麻疹的疗效.方法将126例慢性荨麻疹患者随机分为两组,治疗组68例口服复方甘草酸苷片75 mg,3次/d,咪唑斯汀10 mg,1次/d;对照组58例口服咪唑斯汀10 mg,1次/d.两组疗程均为4周,评估疗效,记录不良反应.结果治疗组和对照组总有效率分别为83.83%和65.52%,差异有显著性(P＜0.05),且无明显不良反应.结论复方甘草酸苷片联合咪唑斯汀治疗慢性荨麻疹疗效好,安全可靠,值得临床推广应用.
목적 관찰복방감초산감편연합미서사정치료만성담마진적료효.방법 장126례만성담마진환자수궤분위량조,치료조68례구복복방감초산감편75 mg,3차/d,미서사정10 mg,1차/d;대조조58례구복미서사정10 mg,1차/d.량조료정균위4주,평고료효,기록불량반응.결과 치료조화대조조총유효솔분별위83.83%화65.52%,차이유현저성(P＜0.05),차무명현불량반응.결론 복방감초산감편연합미서사정치료만성담마진료효호,안전가고,치득림상추엄응용.
Objective To observe the clinical efficacy of Stronger Neo-Minophagen C combined with Mizollen tablets in the treatment chronic urticaria. Methods 126 chronic urticaria patients were divided randomly into two groups. The treatment group(68cases) was treated with Stronger Neo-Minophagen C three times a day and 75 mg per time ,and Mizollen tablets 10 mg one time a day; While the control group(58 cases)was treated with Mizollen tablets 10 mg one time a day. After four weeks, compare effective rate. Results The total effective rate of the treatment group was 83.83% , and the control group was 65.52% , there was significant between the two groups( P ＜ 0. 05 ). And all adverse events were mild and reversible. Conclusion Stronger NeoMinophagen C combined with Mizollen is effective and safe in treating chronic urticaria, and worth to apply to clinical use.